{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:11:04Z","timestamp":1765285864907,"version":"3.46.0"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The efficacy of long-term opioid therapy (LTOT) in treating patients with chronic non-cancer pain (CnCP) is questionable, and the potential risks of adverse effects are well established. The aims were as follows: (1) compare characteristics in patients exposed to LTOT vs non-exposed. (2) Regarding opioid-exposed patients, describe characteristics of patients with risk factors for opioid use disorder or overdose in relation to opioid dosage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted at a Swedish tertiary pain rehabilitation clinic serving CnCP patients. The study population comprised 1,604 patients \u226518 years old registered in the Swedish Quality Registry for Pain Rehabilitation between 2018 and 2020. Data on dispensed opioids were extracted from the Swedish Prescribed Drug Register. Dependent variables were as follows: LTOT vs non-LTOT and exposed opioid dosage &lt;50\u2009mg morphine equivalent\/day (MME\/day) vs \u226550 MME\/day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the included patients, 681 (42.5%) had at least one dispensation of opioids 180 days prior to assessment, 601 with a calculated opioid dosage \u22651 MME\/day, and 424 (26.4%) were exposed to LTOT. The type of opioid prescribed was, in descending order, oxycodone (42.3% of all dispensations), codeine in combination with paracetamol (17.6%), tramadol (13.8%), and morphine (8.1%). A total of 89 cases had dosages of \u226550 MME\/day and 430 patient dosages &lt;50 MME\/day. Patients exposed to LTOT exhibited an increased odds ratio (OR) of 2.685 (95% CI, 1.942\u20133.711) for concomitant use of benzodiazepines and male sex (OR, 1.694; 95% CI, 1.227\u20132.337). Patients receiving doses \u226550 MME\/day were all, except one, exposed to LTOT. The concomitant use of benzodiazepines (OR 1.814, 95% CI 1.264\u20133.331) and male sex (OR, 1.777; 95% CI, 1.178\u20133.102) indicated a higher OR for opioid doses \u226550 MME\/day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LTOT strongly influenced the opioid dose. Furthermore, concomitant benzodiazepine dispensation and male sex were over-represented in patients exposed to LTOT as well as those exposed to opioid doses \u226550 MME\/day.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/sjpain-2024-0025","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T09:41:28Z","timestamp":1734946888000},"source":"Crossref","is-referenced-by-count":1,"title":["Patient characteristics in relation to opioid exposure in a chronic non-cancer pain population"],"prefix":"10.1515","volume":"24","author":[{"given":"Henrik","family":"Grelz","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Center for Primary Health Care Research, Lund University , Jan Waldenstr\u00f6ms Gata 35, 202 13 Malm\u00f6 , Sweden"},{"name":"Department of Neurosurgery and Pain Rehabilitation, Sk\u00e5ne University Hospital , Lasarettsgatan 13, 221 85 Lund , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Jakobsson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Pain Rehabilitation, Sk\u00e5ne University Hospital , Lasarettsgatan 13, 221 85 Lund , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Midl\u00f6v","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Pain Rehabilitation, Sk\u00e5ne University Hospital , Lasarettsgatan 13, 221 85 Lund , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Rivano","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Pain Rehabilitation, Sk\u00e5ne University Hospital , Lasarettsgatan 13, 221 85 Lund , Sweden"},{"name":"Department of Health Sciences, Research Group Rehabilitation Medicine, Lund University, Margaretav\u00e4gen 1B, 222 40 Lund , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Ringqvist","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Center for Primary Health Care Research, Lund University , Jan Waldenstr\u00f6ms Gata 35, 202 13 Malm\u00f6 , Sweden"},{"name":"Department of Neurosurgery and Pain Rehabilitation, Sk\u00e5ne University Hospital , Lasarettsgatan 13, 221 85 Lund , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"2025120910063056475_j_sjpain-2024-0025_ref_001","doi-asserted-by":"crossref","unstructured":"Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287\u2013333. 10.1016\/j.ejpain.2005.06.009.","DOI":"10.1016\/j.ejpain.2005.06.009"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_002","doi-asserted-by":"crossref","unstructured":"Ringqvist A, Dragioti E, Bjork M, Larsson B, Gerdle B. Moderate and stable pain reductions as a result of interdisciplinary pain rehabilitation-A cohort study from the Swedish Quality Registry for Pain Rehabilitation (SQRP). J Clin Med. 2019;8(6):905. 10.3390\/jcm8060905.","DOI":"10.3390\/jcm8060905"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_003","doi-asserted-by":"crossref","unstructured":"Dragioti E, Wiklund T, Alfoldi P, Gerdle B. The Swedish version of the Insomnia Severity Index: Factor structure analysis and psychometric properties in chronic pain patients. Scand J Pain. 2015;9(1):22\u20137. 10.1016\/j.sjpain.2015.06.001.","DOI":"10.1016\/j.sjpain.2015.06.001"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_004","unstructured":"IASP. IASP Statement on opioids; 2018 https:\/\/www.iasp-pain.org\/Advocacy\/OpioidPositionStatement?navItemNumber=7225. Accessed 19 September 2024."},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_005","doi-asserted-by":"crossref","unstructured":"Els C, Jackson TD, Kunyk D, Lappi VG, Sonnenberg B, Hagtvedt R, et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;10:CD012509. 10.1002\/14651858.CD012509.pub2.","DOI":"10.1002\/14651858.CD012509"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_006","doi-asserted-by":"crossref","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain \u2013 United States, 2022. MMWR Recomm Rep. 2022;71(3):1\u201395. 10.15585\/mmwr.rr7103a1.","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_007","doi-asserted-by":"crossref","unstructured":"Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: The SPACE randomized clinical trial. JAMA. 2018;319(9):872\u201382. 10.1001\/jama.2018.0899.","DOI":"10.1001\/jama.2018.0899"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_008","doi-asserted-by":"crossref","unstructured":"Muller AE, Clausen T, Sjogren P, Odsbu I, Skurtveit S. Prescribed opioid analgesic use developments in three Nordic countries, 2006\u20132017. Scand J Pain. 2019;19(2):345\u201353. 10.1515\/sjpain-2018-0307.","DOI":"10.1515\/sjpain-2018-0307"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_009","doi-asserted-by":"crossref","unstructured":"Kallman TF, Backryd E. Prevalence of analgesic use in patients with chronic pain referred to a multidisciplinary pain centre and its correlation with patient-reported outcome measures: A cross-sectional, registry-based study. J Rehabil Med. 2020;52(11):jrm00126. 10.2340\/16501977-2758.","DOI":"10.2340\/16501977-2758"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_010","doi-asserted-by":"crossref","unstructured":"Grelz H, Fischer MR, Priouzifard M, Midlov P, Ringqvist A. Prevalence of long-term opioid therapy in a chronic non-cancer pain population attending a university-based tertiary pain clinic in Sweden. A cross-sectional study. J Rehabil Med. 2022 Apr;54:jrm00270. 10.2340\/jrm.v54.1981.","DOI":"10.2340\/jrm.v54.1981"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_011","doi-asserted-by":"crossref","unstructured":"Campbell G, Nielsen S, Bruno R, Lintzeris N, Cohen M, Hall W, et al. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain. 2015;156(2):231\u201342. 10.1097\/01.j.pain.0000460303.63948.8e.","DOI":"10.1097\/01.j.pain.0000460303.63948.8e"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_012","doi-asserted-by":"crossref","unstructured":"Coleman C, Lennon RP, Robinson JM, Tuan WJ, Sehgal N, Zgierska AE. Opioid dose risk, clinician and patient characteristics, and adherence to opioid prescribing recommendations in chronic non-cancer pain. J Opioid Manag. 2023;19(5):413\u201322. 10.5055\/jom.0815.","DOI":"10.5055\/jom.0815"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_013","doi-asserted-by":"crossref","unstructured":"Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17(1):85\u201398. 10.1111\/pme.12907.","DOI":"10.1111\/pme.12907"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_014","doi-asserted-by":"crossref","unstructured":"Campbell G, Nielsen S, Larance B, Bruno R, Mattick R, Hall W, et al. Pharmaceutical opioid use and dependence among people living with chronic pain: Associations observed within the pain and opioids in treatment (POINT) cohort. Pain Med. 2015;16(9):1745\u201358. 10.1111\/pme.12773.","DOI":"10.1111\/pme.12773"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_015","doi-asserted-by":"crossref","unstructured":"Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315\u201321. 10.1001\/jama.2011.370.","DOI":"10.1001\/jama.2011.370"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_016","doi-asserted-by":"crossref","unstructured":"Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105(10):1776\u201382. 10.1111\/j.1360-0443.2010.03052.x.","DOI":"10.1111\/j.1360-0443.2010.03052.x"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_017","doi-asserted-by":"crossref","unstructured":"Kendler KS, Lonn SL, Ektor-Andersen J, Sundquist J, Sundquist K. Risk factors for the development of opioid use disorder after first opioid prescription: a Swedish national study. Psychol Med. 2023 Oct;53(13):6223\u201331. 10.1017\/S003329172200349X.","DOI":"10.1017\/S003329172200349X"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_018","doi-asserted-by":"crossref","unstructured":"Degenhardt L, Hungerford P, Nielsen S, Bruno R, Larance B, Clare PJ, et al. Pharmaceutical opioid use patterns and indicators of extramedical use and harm in adults with chronic noncancer pain, 2012\u20132018. JAMA Netw Open. 2021;4(4):e213059. 10.1001\/jamanetworkopen.2021.3059.","DOI":"10.1001\/jamanetworkopen.2021.3059"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_019","doi-asserted-by":"crossref","unstructured":"Nazarian A, Negus SS, Martin TJ. Factors mediating pain-related risk for opioid use disorder. Neuropharmacology. 2021;186:108476. 10.1016\/j.neuropharm.2021.108476.","DOI":"10.1016\/j.neuropharm.2021.108476"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_020","doi-asserted-by":"crossref","unstructured":"Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016;157(11):2452\u20137. 10.1097\/j.pain.0000000000000650.","DOI":"10.1097\/j.pain.0000000000000650"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_021","unstructured":"Kaiser U. Secondary and tertiary prevention of chronic pain: International association for the study of pain. Washington, USA: International Association for the Study of Pain; 2020. https:\/\/www.iasp-pain.org\/resources\/fact-sheets\/secondary-and-tertiary-prevention-of-chronic-pain\/. Accessed 19 September 2024."},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_022","unstructured":"Nationellt register \u00f6ver sm\u00e4rtrehabilitering [In Swedish. Swedish Quality Registry for Pain Rehabilitation SQRP]. http:\/\/www.ucr.uu.se\/nrs\/. Accessed 19 September 2024."},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_023","doi-asserted-by":"crossref","unstructured":"Marschall U, L\u2019Hoest H, Radbruch L, Hauser W. Long-term opioid therapy for chronic non-cancer pain in Germany. Eur J Pain. 2016;20(5):767\u201376. 10.1002\/ejp.802.","DOI":"10.1002\/ejp.802"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_024","doi-asserted-by":"crossref","unstructured":"Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed). 1986;292(6516):344. 10.1136\/bmj.292.6516.344.","DOI":"10.1136\/bmj.292.6516.344"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_025","doi-asserted-by":"crossref","unstructured":"Rovner GS, Arestedt K, Gerdle B, B\u00f6rsbo B, McCracken LM. Psychometric properties of the 8-item Chronic Pain Acceptance Questionnaire (CPAQ-8) in a Swedish chronic pain cohort. J Rehabil Med. 2014;46(1):73\u201380. 10.2340\/16501977-1227.","DOI":"10.2340\/16501977-1227"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_026","doi-asserted-by":"crossref","unstructured":"Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29. 10.1186\/1477-7525-1-29.","DOI":"10.1186\/1477-7525-1-29"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_027","doi-asserted-by":"crossref","unstructured":"Rovner G, Johansson F, Gillanders D. Cutoff scores for the 8-item version of the Chronic Pain Acceptance Questionnaire (CPAQ-8) to identify different profiles of pain acceptance patterns, levels of function and behavioral flexibility. J Contextual Behav Sci. 2019;14:146\u201356. 10.1016\/j.jcbs.2019.07.006. Accessed 19 September 2024.","DOI":"10.1016\/j.jcbs.2019.07.006"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_028","doi-asserted-by":"crossref","unstructured":"Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601\u20138. 10.1093\/sleep\/34.5.601.","DOI":"10.1093\/sleep\/34.5.601"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_029","doi-asserted-by":"crossref","unstructured":"Cami J, Farre M. Drug addiction. N Engl J Med. 2003;349(10):975\u201386. 10.1056\/NEJMra023160.","DOI":"10.1056\/NEJMra023160"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_030","doi-asserted-by":"crossref","unstructured":"Ballantyne JC. The brain on opioids. Pain. 2018;159(Suppl 1):S24\u201330. 10.1097\/j.pain.0000000000001270.","DOI":"10.1097\/j.pain.0000000000001270"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_031","doi-asserted-by":"crossref","unstructured":"Fugelstad A, Agren G, Ramstedt M, Thiblin I, Hjelmstrom P. Oxycodone-related deaths in Sweden 2006\u20132018. Drug Alcohol Depend. 2022;234:109402. 10.1016\/j.drugalcdep.2022.109402.","DOI":"10.1016\/j.drugalcdep.2022.109402"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_032","doi-asserted-by":"crossref","unstructured":"Boscarino JA, Hoffman SN, Han JJ. Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates. Subst Abuse Rehabil. 2015;6:83\u201391. 10.2147\/SAR.S85667.","DOI":"10.2147\/SAR.S85667"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_033","doi-asserted-by":"crossref","unstructured":"Gerdle B, Dragioti E, Rivano Fischer M, Ringqvist A. Pain intensity and psychological distress show different associations with interference and lack of life control: A clinical registry-based cohort study of > 40,000 chronic pain patients from SQRP. Front Pain Res (Lausanne). 2023;4:1093002. 10.3389\/fpain.2023.1093002.","DOI":"10.3389\/fpain.2023.1093002"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_034","doi-asserted-by":"crossref","unstructured":"Ghafouri N, Backryd E, Dragioti E, Rivano Fischer M, Ringqvist A, Gerdle B. Effects of interdisciplinary pain rehabilitation programs on neuropathic and non-neuropathic chronic pain conditions \u2013 a registry-based cohort study from Swedish Quality Registry for Pain Rehabilitation (SQRP). BMC Musculoskelet Disord. 2023;24(1):357. 10.1186\/s12891-023-06462-2.","DOI":"10.1186\/s12891-023-06462-2"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_035","doi-asserted-by":"crossref","unstructured":"Gerdle B, Dragioti E, Rivano Fischer M, Ringqvist A. Acceptance and fear-avoidance mediate outcomes of interdisciplinary pain rehabilitation programs at 12-month follow-up: A clinical registry-based longitudinal cohort study from the Swedish Quality Registry for Pain Rehabilitation (SQRP). J Pain Res. 2024;17:83\u2013105. 10.2147\/JPR.S438260.","DOI":"10.2147\/JPR.S438260"},{"key":"2025120910063056475_j_sjpain-2024-0025_ref_036","doi-asserted-by":"crossref","unstructured":"McCracken LM, Morley S. The psychological flexibility model: a basis for integration and progress in psychological approaches to chronic pain management. J Pain. 2014;15(3):221\u201334. 10.1016\/j.jpain.2013.10.014.","DOI":"10.1016\/j.jpain.2013.10.014"}],"container-title":["Scandinavian Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2024-0025\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2024-0025\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:06:21Z","timestamp":1765285581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2024-0025\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,3,7]]}},"alternative-id":["10.1515\/sjpain-2024-0025"],"URL":"https:\/\/doi.org\/10.1515\/sjpain-2024-0025","relation":{},"ISSN":["1877-8879"],"issn-type":[{"type":"electronic","value":"1877-8879"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"20240025"}}